Verapamil prevents post-transplant oliguric renal failure

Area of Science:

• Nephrology
• Transplantation Medicine
• Pharmacology

Background:

• Verapamil demonstrates efficacy in preventing acute renal failure in animal models when administered pre-insult.
• This suggests a potential role for verapamil in preserving cadaveric renal allografts for transplantation.

Purpose of the Study:

• To investigate the efficacy of verapamil in preventing post-transplant acute renal failure.
• To assess the impact of peri-transplant verapamil administration on early graft function.

Main Methods:

• A randomized controlled trial involving 20 renal donors was conducted.
• Donors were assigned to receive either intravenous verapamil (20 mg) or a control treatment.
• Recipients were monitored for acute renal failure indicators including urine output, serum creatinine levels, and dialysis requirements within the first week post-transplant.

Main Results:

• Recipients in the verapamil-treated group exhibited significantly better early urine output (p > 0.01) and serum creatinine levels on day 1 (p > 0.05) compared to the control group.
• These findings suggest a protective effect of verapamil against immediate post-transplant renal dysfunction.

Conclusions:

• Verapamil administration may be beneficial in preventing acute renal failure following kidney transplantation.
• Further research is warranted to determine the optimal dosage and route of administration for verapamil in this context.